News & Updates

In the treatment of patients with aspiration pneumonia, ampicillin–sulbactam helps reduce in-hospital mortality and prevent Clostridioides difficile infection compared with cephalosporins, according to a study from Japan.

For individuals with long COVID, treatment with nirmatrelvir plus ritonavir does not appear to yield improvements in health outcomes when compared with ritonavir alone, according to a phase II study.

A recent study has shown 100-percent engagement in care and viral suppression among 25 adolescents and youth with HIV (AYHIV) being treated with long-acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) during follow-up.

The use of baloxavir marboxil demonstrates good tolerability in children aged <1 year, with no new safety signals seen, according to a study.

Maternal influenza vaccination during pregnancy appears to reduce the incidence of infection in infants, with the protective effect being more pronounced when vaccination is administered in the second or third trimester, according to a study.

The use of SGLT-2 inhibitors does not appear to pose an elevated risk of urinary tract infection (UTI) among male veterans with type 2 diabetes (T2D), a recent study has shown.

COVID-19 appears to have adverse consequences for patients with cancer, including increased hospitalization, treatment disruption, and death, according to a study.

Maternal immunization with the bivalent respiratory syncytial virus (RSV) prefusion F vaccine (RSVpreF) helps lower the incidence of RSV-related lower respiratory tract disease (LRTD) and severe LRTD leading to hospitalization among infants from birth through age 6 months, according to real-world data from the BERNI study.

In patients with invasive fungal disease (IFD) who have few or no treatment options, olorofim demonstrates efficacy and good tolerability, according to the results of a single-arm, open-label phase IIb study.